Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CardioComm Solutions Inc V.EKG

Alternate Symbol(s):  EKGGF

CardioComm Solutions, Inc. is a global medical provider of consumer heart monitoring and medical electrocardiogram (ECG) software solutions. The Company’s technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. It develops advanced software, hardware and core laboratory reading services related to ECG and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians. The Company is also engaged in manufacturing, marketing, and sales of personal ECG monitors direct to consumers. The products are marketed under the HeartCheck brand. It has developed compatibility of the HeartCheck device to its GEMS and GlobalCardio based software to enable use of the device for remote ECG/arrhythmia monitoring services.


TSXV:EKG - Post by User

Bullboard Posts
Comment by juststocks500on Feb 20, 2012 11:02am
253 Views
Post# 19557374

RE: Margins + Insurance

RE: Margins + Insurance

Trust me I fully get your MBA language and the price elasticity paradigm.

Of course, until we hit the market, it will be difficult to measure the said sensitivity.

But I'm inclined to think these factors will come into play also:

1. Any heart issue is a serious issue. This alone will command an advantageous price. People will want it first and then complain to their insurrance company to get it reimbursed or at the very least subsidiezed. Perhaps the ECG reviews by the cardiologiste will be totally reimbursed.

2. Teenagers are able to cough up to $100 in the blink of an eye to get a tech gadget. Recall when the MP3 players, IPODS, etc came out. Surely, many adults will spare 100-150 dollars for a potential life saver. Point being is I don't think people wil think twice about getting it in that range 100-150.

3.  As for margins, my tech background tells me this isn't the most complicated device to produce. Presuming most of the setup costs will be born right off the first order, as someone suggested, profit margins should be around the 80% initially. Especially since we will be at the first stage of the product cycle with no tangible competition. R&D has been absorbed over the last 3 years. Once the novelty wears off, perhaps margins will decline to 60% to further penetrate the market and enlarge the customer base.

4. I believe full featured is the way to go right off the bat leaving nothing for any competitor to grasp. Even for credibility's sake, this must be marketted as high end in order to be taken seriously.  Future enhancements will naturally be brought out by software upgrades which are unavoidable given the constant evolution of the tech environment.

5. Although it could be sold in all Walmart stores (pharmacy), I wouldn't recommend leaning to hard into the "discount" retail end of the spectrum. I'm hoping they distribute first through the more reputed Pharmacies. In other words, I'm hoping they'll be able to breed "brand" success by association with other successfull brands. Their ties with GE certainly indicates they may be doing just that.

As for the target share price. I share the enthusiasm. It's extremely difficult to resist posting a price.

GTLA holders. We truly have a winner here.

Bullboard Posts